PKCε increases phosphorylation of the cardiac myosin binding protein C at serine 302 both in vitro and in vivo

Biochemistry

Volumn 46, Issue 23, 2007, Pages 7054-7061

  Xiao, Lei ^a   Zhao, Qiong ^a   Du, Yanmei ^a   Yuan, Chao ^a   Solaro, R John ^a   Buttrick, Peter M ^a,b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMISTRY; MASS SPECTROMETRY; PHOSPHORYLATION;

CARDIOMYOPATHY; GEL ELECTROPHORESIS; POINT MUTATION;

PROTEINS;

ISOENZYME; MYOSIN BINDING PROTEIN C; PROTEIN KINASE C EPSILON; SERINE; SYNTHETIC PEPTIDE; CARRIER PROTEIN; MYOSIN-BINDING PROTEIN C; PEPTIDE FRAGMENT; PHOSPHOSERINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONSENSUS SEQUENCE; CONTROLLED STUDY; ENZYME ACTIVITY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; MUSCLE FIBRIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; SARCOMERE; TRANSGENIC MOUSE; TWO DIMENSIONAL GEL ELECTROPHORESIS; WESTERN BLOTTING; WILD TYPE; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMAL; CHEMISTRY; ENZYMOLOGY; GENETICS; METABOLISM; MOLECULAR GENETICS; PHOSPHORYLATION;

MUS; MUS MUSCULUS;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMALS; CARDIOMYOPATHY, DILATED; CARRIER PROTEINS; CONSENSUS SEQUENCE; MICE; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PHOSPHORYLATION; PHOSPHOSERINE; PROTEIN KINASE C-EPSILON; SERINE;

EID: 34250182384     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi700467k     Document Type: Article

References (52)

1. Rybin, V. O., and Steinberg, S. F. (1994) Protein kinase C isoform expression and regulation in the developing rat heart, Circ. Res. 74, 299-309.
2. Rybin, V., and Steinberg, S. F. (1997) Do adult rat ventricular myocytes express protein kinase C-alpha?, Am. J. Physiol. 272, H2485-H2491.
3. Mochly-Rosen, D., Henrich, C. J., Cheever, L., Khaner, H., and Simpson, P. C. (1990) A protein kinase C isozyme is translocated to cytoskeletal elements on activation, Cell Regul. 1, 693-706.
4. Dorn, G. W., Robbins, J., and Sugden, P. H. (2003) Phenotyping hypertrophy: eschew obfuscation, Circ. Res. 92, 1171-1175.
5. Bowman, J. C., Steinberg, S. F., Jiang, T., Geenen, D. L., Fishman, G. I., and Buttrick, P. M. (1997) Expression of protein kinase C beta in the heart causes hypertrophy in adult mice and sudden death in neonates, J. Clin. Invest. 100, 2189-2195.
6. Takeishi, Y., Chu, G., Kirkpatrick, D. M., Li, Z., Wakasaki, H., Kranias, E. G., King, G. L., and Walsh, R. A. (1998) In vivo phosphorylation of cardiac troponin 1 by protein kinase Cbeta2 decreases cardiomyocyte calcium responsiveness and contractility in transgenic mouse hearts, J. Clin. Invest. 102, 72-78.
7. Dorn, G. W., Souroujon, M. C., Liron, T., Chen, C. H., Gray, M. O., Zhou, H. Z., Csukai, M., Wu, G., Lorenz, J. N., and Mochly-Rosen, D. (1999) Sustained in vivo cardiac protection by a rationally designed peptide that causes epsilon protein kinase C translocation, Proc. Natl. Acad. Sci. U.S.A. 96, 12798-12803.
8. Burkart, E. M., Sumandea, M. P., Kobayashi, T., Nili, M., Martin, A. F., Homsher, E., and Solaro, R. J. (2003) Phosphorylation or glutamic acid substitution at protein kinase C sites on cardiac troponin 1 differentially depress myofilament tension and shortening velocity, J. Biol. Chem. 278, 11265-11272.
9. Wang, J., Liu, X., Arneja, A. S., and Dhalla, N. S. (1999) Alterations in protein kinase A and protein kinase C levels in heart failure due to genetic cardiomyopathy, Can. J. Cardiol. 15, 683-690.
10. Inagaki, K., Iwanaga, Y., Sarai, N., Onozawa, Y., Takenaka, H., Mochly-Rosen, D., and Kihara, Y. (2002) Tissue angiotensin II during progression or ventricular hypertrophy to heart failure in hypertensive rats; differential effects on PKC epsilon and PKC beta, J. Mol. Cell Cardiol. 34, 1377-1385.
11. Koide, Y., Tamura, K., Suzuki, A., Kitamura, K., Yokoyama, K., Hashimoto, T., Hirawa, N., Kihara, M., Ohno, S., and Umemura, S. (2003) Differential induction of protein kinase C isoforms at the cardiac hypertrophy stage and congestive heart failure stage in Dahl salt-sensitive rats, Hypertens. Res. 26, 421-426.
12. Sabri, A., Wilson, B. A., and Steinberg, S. F. (2002) Dual actions of the Galpha(q) agonist Pasteurella multocida toxin to promote cardiomyocyte hypertrophy and enhance apoptosis susceptibility, Circ. Res. 90, 850-857.
13. Sabri, A., and Steinberg, S. F. (2003) Protein kinase C isoform-selective signals that lead to cardiac hypertrophy and the progression of heart failure, Mol. Cell. Biochem. 251, 97-101.
14. Shizukuda, Y., and Buttrick, P. M. (2002) Subtype specific roles of beta-adrenergic receptors in apoptosis of adult rat ventricular myocytes, J. Mol. Cell Cardiol. 34, 823-831.
15. Goldspink, P. H., Montgomery, D. E., Walker, L. A., Urboniene, D., McKinney, R. D., Geenen, D. L., Solaro, R. J., and Buttrick, P. M. (2004) Protein kinase Cepsilon overexpression alters myofilament properties and composition during the progression of heart failure, Circ. Res. 95, 424-432.
16. Montgomery, D. E., Rundell, V. L., Goldspink, P. H., Urboniene, D., Geenen, D. L., de Tombe, P. P., and Buttrick, P. M. (2005) Protein kinase C epsilon induces systolic cardiac failure marked by exhausted inotropic reserve and intact Frank-Starling mechanism, Am. J. Physiol. Heart Circ. Physiol. 289, H1881-H1888.
17. Kamisago, M., Sharma, S. D., DePalma, S. R., Solomon, S., Sharma, P., McDonough, B., Smoot, L., Mullen, M. P., Woolf, P. K., Wigle, E. D., et al. (2000) Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy, N. Engl. J. Med. 343, 1688-1696.
18. Ahmad, F., Seidman, J. G., and Seidman, C. E. (2005) The genetic basis for cardiac remodeling, Annu. Rev. Genomics Hum. Genet. 6, 185-216.
19. Moos, C., Offer, G., Starr, R., and Bennett, P. (1975) Interaction of C-protein with myosin, myosin rod and light meromyosin, J. Mol. Biol. 97, 1-9.
20. Alyonycheva, T. N., Mikawa, T., Reinach, F. C., and Fischman, D. A. (1997) Isoform-specific interaction of the myosin-binding proteins (MyBPs) with skeletal and cardiac myosin is a property of the C-terminal immunoglobulin domain, J. Biol. Chem. 272, 20866-20872.
21. Stan, R., and Offer, G. (1978) The interaction of C-protein with heavy meromyosin and subfragment-2, Biochem. J. 171, 813-816.
22. Gruen, M., and Gautel, M. (1999) Mutations in beta-myosin S2 that cause familial hypertrophic cardiomyopathy (FHC) abolish the interaction with the regulatory domain of myosin-binding protein-C, J. Mol. Biol. 286, 933-949.
23. Koretz, J. F., Irving, T. C. and Wang, K. (1993) Filamentous aggregates of native titin and binding of C-protein and AMP-deaminase, Arch. Biochem. Biophys. 304, 305-309.
24. Freiburg, A., and Gautel, M. (1996) A molecular map of the interactions between titin and myosin-binding protein C. Implications for sarcomeric assembly in familial hypertrophic cardiomyopathy, Eur. J. Biochem. 235, 317-323.
25. Seiler, S. H., Fischman, D. A., and Leinwand, L. A. (1996) Modulation of myosin filament organization by C-protein family members, Mol. Biol. Cell 7,113-127.
26. Welikson, R. E., and Fischman, D. A. (2002) The C-terminal IgI domains of myosin-binding proteins C and H (MyBP-C and MyBP-H) are both necessary and sufficient for the intracellular crosslinking of sarcomeric myosin in transfected non-muscle cells, J. Cell Sci. 115, 3517-3526.
27. Hanis, S. P., Bartley, C. R., Hacker, T. A., McDonald, K. S., Douglas, P. S., Greaser, M. L., Powers, P. A., and Moss, R. L. (2002) Hypertrophic cardiomyopathy in cardiac myosin binding protein-C knockout mice, Circ. Res. 90, 594-601.
28. Sadayappan, S., Gulick, J., Osinska, H., Martin, L. A., Hahn, H. S., Dorn, G. W., Klevitsky, R., Seidman, C. E., Seidman, J. G., and Robbins, J. (2005) Cardiac myosin-binding protein-C phosphorylation and cardiac function, Circ. Res. 97, 1156-1163.
29. Jeacocke, S. A., and England, P. J. (1980) Phosphorylation of a myofibrillar protein of Mr 150 000 in perfused rat heart, and the tentative indentification of this as C-protein, FEBS Lett. 122, 129-132.
30. Lim, M. S., and Walsh, M. P. (1986) Phosphorylation of skeletal and cardiac muscle C-proteins by the catalytic subunit of cAMP-dependent protein kinase, Biochem. Cell Biol. 64, 622-630.
31. Garvey, J. L., Kranias, E. G., and Solaro, R. J. (1988) Phosphorylation of C-protein, troponin I and phospholamban in isolated rabbit hearts, Biochem. J. 249, 709-714.
32. Venema, R. C., and Kuo, J. F. (1993) Protein kinase C-mediated phosphorylation of troponin I and C-protein in isolated myocardial cells is associated with inhibition of myofibrillar actomyosin MgATPase, J. Biol. Chem. 268, 2705-2711.
33. Hartzell, H. C., and Titus, L. (1982) Effects of cholinergic and adrenergic agonists on phosphorylation of a 165,000-dalton myofibrillar protein in intact cardiac muscle, J. Biol. Chem. 257, 2111-2120.
34. Lim, M. S., Sutherland, C., and Walsh, M. P. (1985) Phosphorylation of bovine cardiac C-protein by protein kinase C, Biochem. Biophys. Res. Commun. 132, 1187-1195.
35. Mohamed, A. S., Dignam, J. D., and Schlender, K. K. (1998) Cardiac myosin-binding protein C (MyBP-C): identification of protein kinase A and protein kinase C phosphorylation sites, Arch. Biochem. Biophys. 358, 313-319.
36. Weisberg, A., and Winegrad, S. (1996) Alteration of myosin cross bridges by phosphorylation of myosin-binding protein C in cardiac muscle, Proc. Natl. Acad. Sci. U.S.A. 93, 8999-9003.
37. Yuan, C., Guo, Y., Ravi, R., Przyklenk, K., Shilkofski, N., Diez, R., Cole, R. N., and Murphy, A. M. (2006) Myosin binding protein C is differentially phosphorylated upon myocardial stunning in canine and rat hearts - evidence for novel phosphorylation sites, Proteomics 6, 4176-4186.
38. Unlu, M., Morgan, M. E., and Minden, J. S. (1997) Difference gel electrophoresis: a single gel method for detecting changes in protein extracts, Electrophoresis 18, 2071-2077.
39. Tonge, R., Shaw, J., Middleton, B., Rowlinson, R., Rayner, S., Young, J., Pognan, F., Hawkins, E., Currie, I., and Davison, M. (2001) Validation and development of fluorescence two-dimensional differential gel electrophoresis proteomics technology, Proteomics 1, 377-396.
40. Palmer, B. M., Georgakopoulos, D., Janssen, P. M., Wang, Y., Alpert, N. R., Belardi, D. F., Hanis, S. P., Moss, R. L., Burgon, P. G., Seidman, C. E., et al. (2004) Role of cardiac myosin binding protein C in sustaining left ventricular systolic stiffening, Circ. Res. 94, 1249-1255.
41. Sato, N., Kawakami, T., Nakayama, A., Suzuki, H., Kasahara, H., and Obinata, T. (2003) A novel variant of cardiac myosin-binding protein-C that is unable to assemble into sarcomeres is expressed in the aged mouse atrium, Mol. Biol. Cell 14, 3180-3191.
42. Marouga, R., David, S., and Hawkins, E. (2005) The development of the DIGE system: 2D fluorescence difference gel analysis technology, Anal Bioanal. Chem. 382, 669-678.
43. Kates, S. A., (2000) Solid phase synthesis, A practical guide, Marcel Dekker, New York and Basel.
44. Lee, B. S., Krishnanchettiar, S., Lateef, S. S., Lateef, N. S., and Gupta, S. (2005) Characterization of oligosaccharide moieties of intact glycoproteins by microwave-assisted partial acid hydrolysis and mass spectrometry, Rapid Commun. Mass Spectrom. 19, 2629-2635.
45. Coligan, J. E. (1996) Current Protocols in Immunology, Vol. 2, John Wiley & Sons, New York.
46. Zhao, Q., Brauer, P. R., Xiao, L., McGuire, M. H., and Yee, J. A. (2002) Expression of parathyroid hormone-related peptide (PthrP) and its receptor (PTH1R) during the histogenesis of cartilage and bone in the chicken mandibular process, J. Anat. 201, 137-151.
47. Blom, N., Gammeltoft, S., and Brunak, S. (1999) Sequence and structure-based prediction of eukaryotic protein phosphorylation sites, J. Mol. Biol. 294, 1351-1362.
48. Kasahara, H., Itoh, M., Sugiyama, T., Kido, N., Hayashi, H., Saito, H., Tsukita, S., and Kato, N. (1994) Autoimmune myocarditis induced in mice by cardiac C-protein. Cloning of complementary DNA encoding murine cardiac C-protein and partial characterization of the antigenic peptides, J. Clin. Invest. 94, 1026-1036.
49. Johnsen, D. D., Kacimi, R., Anderson, B. E., Thomas, T. A., Said, S., and Gerdes, A. M. (2005) Protein kinase C isozymes in hypertension and hypertrophy: insight from SHHF rat hearts, Mol. Cell. Biochem. 270, 63-69.
50. Roman, B. B., Goldspink, P. H., Spaite, E., Urboniene, D., McKinney, R., Geenen, D. L., Solaro, R. J., and Buttrick, P. M. (2004) Inhibition of PKC phosphorylation of cTnI improves cardiac performance in vivo, Am. J. Physiol. Heart Circ. Physiol. 286, H2089-H2095.
51. Scruggs, S. B., Walker, L. A., Lyu, T., Geenen, D. L., Solaro, R. J., Buttrick, P. M., and Goldspink, P. H. (2006) Partial replacement of cardiac troponin I with a non-phosphorylatable mutant at serines 43/45 attenuates the contractile dysfunction associated with PKCepsilon phosphorylation, J. Mol. Cell Cardiol. 40, 465-473.
52. Decker, R. S., Decker, M. L., Kulikovskaya, I., Nakamura, S., Lee, D. C., Harris, K., Klocke, F. J., and Winegrad, S. (2005) Myosin-binding protein C phosphorylation, myofibril structure, and contractile function during low-flow ischemia, Circulation 111, 906-912.